chemXplore tracks 20 projects in India, of which 12 are active.
Of the active ones, 8 new construction, 3 expansion and 1 revamp / retrofit.
7 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
Adds local production of pMDI valves, breath‑actuated inhalation devices and multi dose nasal spray systems; site grows to 11,300 m² to improve regional supply resilience.
Chennai plant will produce NXT™ P97 silane for IMEA and Asia‑Pacific, improving supply and access to a 79% renewable‑carbon silane for silica‑reinforced tire treads.
Post‑hoc ATTAIN‑1 modelling: oral orforglipron cut predicted 10‑year type 2 diabetes risk up to 57% and cardiovascular risk up to 18% versus placebo at 72 weeks.
Once‑daily oral GLP‑1 cut MACE vs insulin glargine, lowered A1C by 1.6% at 52 weeks and produced mean weight loss of 8.1 kg with durable effects to 104 weeks.
Investment will link a Minnesota iron-ore mine with a new Iowa steel complex using DRI and EAF technology to produce 100% US steel and create thousands of jobs.
An indirect, covariate‑adjusted comparison of SURMOUNT‑1 and STEP UP data shows larger mean and categorical weight‑loss benefits with tirzepatide 10 mg and 15 mg at 72 weeks.
FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.
Third line comprises 2,300 t/d ammonia and 4,000 t/d single-line urea (ACES21™); built adjacent to existing Port Harcourt complex; awarded 2023, completed June 2026.
Advanced feasibility study for an MDI complex on secured Dahej land; final decision pending approvals. Project aims to serve India and neighbouring markets with local MDI supply.
Selective growth in electronics, healthcare and mobility; €300–€400m annual investment; PACE to save >€300m/year from 2028; Net Zero by 2045.
